Results 71 to 80 of about 1,597 (198)
BACKGROUND: Blood transfusion therapy is the main therapy for thalassemia patients. Active reporting of acute reactions during blood transfusions can play a pivotal role in the prevention of under-reporting of these events.
Anuf Iqbal, Iqra Aroob, Nazish Saqlain
doaj +1 more source
It is important to recognize the significance of acute painful transfusion reactions (APTRs) as a complication of blood transfusions. These adverse reactions are characterized by the onset of acute pain after the administration of blood components ...
Sophia Delicou +5 more
doaj +1 more source
DART–A Voluntary System of Hemovigilance in Denmark [PDF]
SUMMARyDenmark has a long tradition of collecting information concerning the country's activities, and this includes the collation of data concerning transfusion medicine. Data concerning nearly all parts of the transfusion chain, from the giving of blood through to the production of blood components and to the registration of transfusion complications,
Jan Jørgensen, Ellen Taaning
openaire +1 more source
Abstract Background Acute pain transfusion reaction (APTR) is a rare, under‐recognized condition of unknown etiology. It can cause significant distress in recipients, necessitating symptomatic management and, occasionally, hospitalization. Study Design and Methods Here, we present an APTR event in an adult subject with transfusion‐dependent thalassemia
Georgia Tzafa +20 more
wiley +1 more source
Hemovigilance: is it making a difference to safety in the transfusion chain? [PDF]
Hemovigilance is the systematic monitoring of adverse reactions and incidents in the transfusion chain in order to make recommendations for safety improvement.
Wiersum-Osselton, J.C.
core
Hemovigilance: a momentous step to blood safety
Hemovigilance is a series of monitoring procedures that cover the entire transfusion chain, from blood and its component collection to recipient follow-up, collecting and collecting information about unexpected or adverse effects resulting from the therapeutic use of unstable blood products.
Rasika S. Khobragade +3 more
openaire +1 more source
When blood is needed but not available: A proposal for measuring patient‐level blood unavailability
Transfusion, EarlyView.
Shreenik Kundu +3 more
wiley +1 more source
Abstract Background The BORN trial suggested that using cord blood‐red blood cells (CB‐RBCs) to transfuse severely preterm neonates significantly improves clinical outcomes compared to standard adult donor RBCs (A‐RBC). Study Design and Methods The study illustrates CB‐RBC concentrate production and inventory management across nine CB banks ...
Claudio Pellegrino +38 more
wiley +1 more source
Hemovigilance, heterogeneity, and hyperfibrinolysis : evaluating the Netherlands' switch to solvent/detergent plasma [PDF]
Post-marketing study evaluating the Netherlands' switch from fresh frozen plasma (FFP) to solvent/detergent (SD) plasma. Compares FFP to SD plasma via meta-analysis, large cohort study, and lab study with methodological issues unique to ...
Saadah, N.H.
core
ABSTRACT Massive transfusion protocols are essential in trauma resuscitation but may inadvertently increase the risk of acute hemolytic transfusion reactions (AHTRs), which are typically caused by ABO incompatibility. Recognition is difficult because signs of hemolysis can mimic trauma‐related hemorrhage or coagulopathy.
Mohammad Javad Entezari Meybodi +3 more
wiley +1 more source

